EUVIMEDEUVIMED entdecken
Open Access

Design of soluble Notch agonists that drive T cell development and boost immunity

Rubul Mout, Ran Jing, Mayuri Tanaka-Yano, Emily D Egan, Helen Eisenach, Martin A Kononov, Roland Windisch, Mohamad Ali Toufic Najia, Allison Tompkins, Luca Hensch, Trevor Bingham, Rajesh Gunage und 12 weitere

Cell · 2025-10 · 188 (21) · 5980-5994.e28

DOI: 10.1016/j.cell.2025.07.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2025-10. Verfasst von Rubul Mout und 23 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell & Regenerative Biology Program, Boston Children's Hospital, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmac…. Hauptthemen laut MEDLINE: Receptors, Notch, T-Lymphocytes. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rational design of receptor agonists to control cell signaling is an emerging strategy for developing disease therapeutics. Creating a soluble cytokine-like agonist for the Notch receptor, which regulates cell fate in embryonic and adult development, is challenging, as receptor activation requires a mechanical force that is usually mediated by cell-associated transmembrane ligands. Here, we exploit computationally designed protein complexes with precise valencies and geometries to generate soluble cytokine-like Notch agonists. These molecules promote cell-cell bridging, cluster Notch receptors at cell synapses, and activate receptor signaling. We show that these agonists drive T cell differentiation from cord blood progenitors and human induced pluripotent stem cells (iPSCs) and in bioreactor production of T cells in liquid suspension. When delivered intravenously in mice, they stimulate cytokine production, expansion of antigen-specific CD4+ T cells, and antibody class switching. These de-novo-designed ligands can be broadly applied to optimize in vitro cell differentiation and advance immunotherapy development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, NotchT-LymphocytesAnimalsHumansMiceInduced Pluripotent Stem CellsCell DifferentiationSignal TransductionLigandsCD4-Positive T-LymphocytesCytokinesFetal Blood

Stichwörter der Autor:innen

Notch signalingT cell developmentT cell immunitycomputational protein designiPSC-derived T cellsimmunotherapyprotein agonistsoluble Notch activationvaccine

Substanzen

Receptors, NotchLigandsCytokines

Autor:innen und Institutionen

  • Stem Cell & Regenerative Biology Program, Boston Children's Hospital, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115,…
  • Stem Cell & Regenerative Biology Program, Boston Children's Hospital, Boston, MA 02115, USA.
  • Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Department of Biochemistry, University of Washington, Seattle, WA 98195, USA; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
  • Stem Cell & Regenerative Biology Program, Boston Children's Hospital, Boston, MA 02115, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA.
  • Department of Biochemistry, University of Washington, Seattle, WA 98195, USA; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA; Medical Scientist Training Program, University of Washington,…

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • NCI NIH HHS
  • Cancerfonden
  • Vetenskapsrådet
  • National Institutes of Health
  • Boston Children's Hospital
  • Massachusetts Life Sciences Center

Zitieren

APA

Mout, R., Jing, R., Tanaka-Yano, M., Egan, E. D., Eisenach, H., Kononov, M. A., Windisch, R., Najia, M. A. T., Tompkins, A., Hensch, L., Bingham, T., Gunage, R., Zhao, Y., Edman, N. I., Li, C., Wang, D., Schlaeger, T. M., Zon, L. I., North, T. E., …, & Daley, G. Q. (2025). Design of soluble Notch agonists that drive T cell development and boost immunity. Cell, 188(21), 5980-5994.e28. https://doi.org/10.1016/j.cell.2025.07.009

Vancouver

Mout R, Jing R, Tanaka-Yano M, Egan ED, Eisenach H, Kononov MA, et al. Design of soluble Notch agonists that drive T cell development and boost immunity. Cell. 2025;188(21):5980-5994.e28. doi:10.1016/j.cell.2025.07.009

BibTeX
@article{Mout2025,
  author = {Mout, Rubul and Jing, Ran and Tanaka-Yano, Mayuri and Egan, Emily D and Eisenach, Helen and Kononov, Martin A and Windisch, Roland and Najia, Mohamad Ali Toufic and Tompkins, Allison and Hensch, Luca and Bingham, Trevor and Gunage, Rajesh and Zhao, Yunliang and Edman, Natasha I and Li, Christopher and Wang, Dahai and Schlaeger, Thorsten M and Zon, Leonard I and North, Trista E and Lendahl, Urban and Rowe, R Grant and Baker, David and Blacklow, Stephen C and Daley, George Q},
  title = {Design of soluble Notch agonists that drive T cell development and boost immunity},
  journal = {Cell},
  year = {2025},
  volume = {188},
  number = {21},
  pages = {5980--5994.e28},
  doi = {10.1016/j.cell.2025.07.009}
}
Kostenlos starten →